Early Lung Cancer Screening: A Comparative Study of CNN and Radiomics Models with Pulmonary Nodule Biologic Characterization

2.1 Biology of Pulmonary Nodules

According to the American Lung Association, a lung nodule is defined as a small mass of dense tissue on the lung (3). These nodules, also referred to as pulmonary nodules, can be either benign or malignant. Benign pulmonary nodules are non-cancerous and often result from infections, inflammatory conditions, or non-cancerous growths. Malignant nodules, on the other hand, indicate lung cancer or metastasis from other cancers.

The likelihood of a nodule being cancerous (malignant) is often related to its size, as pulmonary nodules are less than 3 centimeters in diameter. Nodules larger than this size are typically referred to as masses and may have a higher likelihood of being malignant. Other factors contributing to the formation of malignant nodules include cancer cells spreading from other parts of the body through the bloodstream or lymphatic system to the lungs, leading to metastatic cancer. However, on the contrary primary lung cancer arises when cells within the lung tissue undergo genetic mutations that cause uncontrolled growth, forming malignant nodules.

Malignant nodules tend to be larger than benign nodules, typically over 1 centimeter in diameter, although they can be smaller in the early stages. The edges of malignant nodules are usually ill-defined and blurry because the cancer cells invade surrounding lung tissue. Malignant nodules grow rapidly over time, with a shorter doubling time (the time it takes for the nodule to double in size) often between 1 and 6 months and unlike benign nodules, malignant nodules typically do not have classic benign calcification patterns (e.g., central, laminated, popcorn-like). If calcification is present, it tends to be eccentric or stippled. Malignant nodules can be located anywhere in the lung but are often found in the upper lobes. Central nodules may involve the major airways.

• Download figure
• Open in new tab

Figure 1:

CT scan images show lung nodules with different locations and shapes.

2.2 CNN Model and the Current Advancements

Utilizing Convolutional Neural Network (CNN) to medical imaging research has made remarkable advancements toward early detection of lung cancer. Recent work has shown that CNNs can process complex image data for the accurate detection of malignant pulmonary nodules, as well as several subtypes of Lung Cancer: Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma, etc. Models such as VGG16 perform very well when using pre-trained feature extractors, with fine-tuning on specific tasks. CNNs have now reached sensitivity and specificity rates that are higher than those traditional feature-based methods, as well as greater order of magnitude in their ability to learn autonomously and extract relevant features from raw CT-scan images. Improvements to solutions based on continuous enhancement in the architectures of CNNs, optimization techniques, and computational power have further upgraded its performance to be an indispensable tool in medical diagnosis. Table 1 shows performance of a few classifiers on Lung CT Scan.

3.1 CNN Model Development

For the dataset, the proposed CNN model in the paper used a total of 36,300 images compiled from three separate datasets. The first and second datasets consisted of a total of 28800 infected lung images obtained from the publicly available online source “Kaggle” and the Cancer Imaging Archive (17; 15; 16; 19). Whereas, the third and last datasets consisted of 7,500 normal CT-Scans of lungs from the publicly available online source “Kaggle” and “National Cancer Institute (14; 18).

• Download figure
• Open in new tab

Figure 2:

The Architecture of the CNN Model

The images were preprocessed by resizing them to (100, 100) and normalizing pixel values to the range [0, 1]. The datasets were then separated into two classes: “Infected Cases” and “Normal cases.” The dataset was split into training (80%), validation (10%), and test (10%)

The Convolutional Neural Network (CNN) model utilized the pre-trained VGG16 model as a feature extractor. The layers of the VGG16 model were then frozen to retain pre-trained weights. An additional sequential model was constructed with added dense layers for classification. The model was compiled with the Adam optimizer to minimize error functions between predicted values and actual target values. The Adam optimizer was chosen for its increased efficient convergence rates and robustness across diverse problem domains.

3.2 Radiomics-based Model

The model by Choi et al (1)., on the other hand, is trained to categorize the PN as benign or malignant via the extraction of quantitative features from the CT images of the nodule mechanically. The model is formulated using 103 radiomic features categorized into three groups: intensity, shape, and texture. Intensity is one of the first-order statistical measures that describe the distribution of pixel values within the PN; it contains features like mean intensity and standard deviation. Geometric shape features characterize volume, surface area, and bounding box dimensions. Texture features from the GLCM and GLRM measure spatial patterns of pixel intensities and reflect an intuition regarding tissue heterogeneity.

They used hierarchical clustering to reduce overfitting and reduce the feature space by bringing together relevant features within the unit. This is among the most powerful techniques applied to a given set of features in the entire methods discussed in this review. The correlations between similar features have been clustered, with each cluster being allowed only one representative feature. This process resulted in a refined set of features, which have much less redundancy than the initial features. In other words, they are more informatic.

A support vector machine classifier was applied with the LASSO to construct the model. SVM is a robust classification algorithm that finds an optimal hyperplane to classify different classes. LASSO adds a regularization term for the absolute size of coefficients to perform feature selection and reduce overfitting effectively. The performance of such a model was assessed using 10×10-fold cross-validation; therefore, the data set was repeatedly divided into training and validation sets. This provided a very accurate way of estimating model fit values for both in-sample and out-of-sample data.

3.3 Radiomics and Nodule Detection

Radiomics is the extraction of many quantitative features from medical images using sophisticated data characterization algorithms. This approach may be beneficial in analyzing subtle changes in the biology of pulmonary nodules. It possibly could be crucial for differentiating benign from malignant growths and improving early lung cancer detection.

Radiomics exploits information in LDCT scans to extract features describing the intensity, shape, and texture of the nodule. The first features are intensity features, which are the first-order statistical measures that describe pixel value distribution that exists in the nodule and include metrics like mean intensity and standard deviation.

Shape-based features define the volume of the nodule, its surface area, and the size of the minimum bounding box. Texture features are approximations of GLCM and GLRM, which are used for estimating spatial patterns of pixel intensities reflecting tissue heterogeneity.

In the model by Choi et al., 103 radiomic features are classified into intensity, shape, and texture for classifying pulmonary nodules as malignant or benign. Hierarchical clustering was used to reduce the likelihood of overfitting and increase the relevance of the features; hence, highly correlated features were grouped in the process and allowed only one representative feature from each cluster.

3.4 Comparison of Models

The performance of the CNN model and the radiomics-based model was evaluated using the following metrics: accuracy, sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC-ROC). For the CNN model, the evaluation was conducted on a 10% test split of the LIDC-IDRI dataset (19). The cross-validation of the proposed VGG16 model was done on a separate dataset from Mendeley Data (20). This dataset comprised CT scan images collected from hospitals in Iran, including 364 images with 238 classified as cancerous and 126 as non-cancerous. The images were meticulously labeled with the assistance of a pulmonologist to ensure accurate classification and to avoid any potential errors.

In contrast, the radiomics-based model was tested using the LIDC-IDRI dataset, consisting of 72 pulmonary nodules (31 benign and 41 malignant). The radiomics-based model’s performance was further validated using additional cross-validation techniques, including 20×5-fold and 50×2-fold cross-validations, to ensure the stability and generalizability of the model.